Feb 08, 2024 9:31am EST FibroBiologics Announces Three United States Patents for Fibroblast Technology
Jan 31, 2024 10:00am EST FibroBiologics Announces Direct Listing on NASDAQ Under the Stock Ticker FBLG
Sep 12, 2023 8:15am EDT FibroBiologics Dedicates Laboratory Facility as the Newlin-Linscomb Lab for Cell Therapeutics
Jun 01, 2023 4:37pm EDT FibroBiologics to Present Corporate Update at 2023 BIO International Convention
Feb 24, 2023 9:07am EST FibroBiologics Sets Another Record as Highest Amount Raised per Biotech Investor in StartEngine.com History